Mammalian Polyclonal IgG Antibody Market Growth $1.21 Billion By 2025 | Grand View Research Inc.

Posted on 2019-08-22 by researchinsights in Biotech, Healthcare // 0 Comments

San Francisco, United States, 2019-Aug-22 — /EPR Network/ —

The global mammalian polyclonal IgG antibody market size is expected to reach USD 1.21 billion by 2025 expanding at a CAGR of 5.1%, according to a new report by Grand View Research, Inc. Advantages over other forms of antibodies, increasing global R&D investments, and rising adoption of novel diagnostic procedures are factors driving the market. Global rise in chronic and infectious diseases also play a key role in propelling the market growth.

Polyclonal antibodies are the most preferred choice in routine laboratory tests, such as ELISA, microarray assays, western blotting, flow cytometry, and immunohistochemistry. Production of these does not require skilled professionals and large batches can be produced as per client requirements. A polyclonal antibody can recognize multiple antigens on one epitope and therefore can be utilized in the study of various diseases ranging from cancer to metabolic diseases. Denatured proteins are often detected with the use of polyclonal antibodies.

Thus, increasing use of these products in the treatment of several chronic diseases is also anticipated to fuel growth in the near future. Rising investments by major pharma companies, such as Novartis and Roche, for the development of therapeutic antibodies and novel diagnostic techniques and for QC purposes are also driving the market growth. For instance, R&D investments by top 10 biotech companies increased from USD 8.2 billion in 2010 to USD 10.2 billion in 2016, accounting for a 13% increase.

To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/mammalian-polyclonal-igg-antibody-market

Further key findings from the study suggest:

Large amount of polysera obtained from goats and predominant use of these animals as hosts has contributed to its large market share in 2017
Metabolic biomarkers are expected to hold the largest market share during the forecast period due to growing prevalence of chronic diseases, such as cardiovascular diseases (CVDs) and cancer
ELISA tests provide accurate diagnosis of disease, such as AIDS, Lyme disease, syphilis, pernicious anemia, Rocky Mountain spotted fever, squamous cell carcinoma, chickenpox, shingles, and other bacterial and viral infections, than other antibody-based assays contributing to its high market share
Availability of technologically advanced equipment and presence of major market players has attributed to the North American region garnering large market share
Asia Pacific is anticipated to gain significant market share in near future due to rising R&D investment and presence of target population
Few key companies in the global mammalian polyclonal IgG antibody market include Abcam PLC; Bio-Rad Laboratories, Inc.; Thermo Fisher Scientific; Merck KgaA; Cell Signaling Technologies, Inc.; and Hoffmann-La Roche Ltd.

Related Reports on Biotechnology:

Grand View Research has segmented the global mammalian polyclonal IgG antibody market on the basis of type, product, application, end use, and region:

Mammalian Polyclonal IgG Antibody Type Outlook (Revenue, USD Million, 2014 – 2025)

Goat
Rabbit
Horse
Mouse
Others

Mammalian Polyclonal IgG Antibody Product Outlook (Revenue, USD Million, 2014 – 2025)

Cardiac Markers
Metabolic Markers
Renal Markers
Others

Mammalian Polyclonal IgG Antibody Application Outlook (Revenue, USD Million, 2014 – 2025)

ELISA
Immunoturbidometry
Immunoelectrophoresis
Antibody Identification
Immunohistochemistry
Immunocytochemistry
Western Blotting

Mammalian Polyclonal IgG Antibody End Use Outlook (Revenue, USD Million, 2014 – 2025)

Hospitals
Diagnostic Centers
Academic and Research Centers

Mammalian Polyclonal IgG Antibody Regional Outlook (Revenue, USD Million, 2014 – 2025)

North America
- U.S.
- Canada
Europe
- U.K.
- Germany
- France
- Italy
- Spain
Asia Pacific
- Japan
- China
- India
Latin America
- Brazil
- Mexico
MEA
- South Africa
- Saudi Arabia

For Press Release of This Research Report by Grand View Research:

https://www.grandviewresearch.com/press-release/global-mammalian-polyclonal-igg-antibody-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Matched content

Editor’s pick